| CRN++: Molecular programming language M Vasić, D Soloveichik, S Khurshid Natural Computing 19 (2), 391-407, 2020 | 57 | 2020 |
| Sudden death: Neurogenic causes, prediction and prevention N Japundžić-Žigon, O Šarenac, M Lozić, M Vasić, T Tasić, D Bajić, ... European journal of preventive cardiology 25 (1), 29-39, 2018 | 43 | 2018 |
| Heart rate dynamics in doxorubicin-induced cardiomyopathy T Lončar-Turukalo, M Vasić, T Tasić, G Mijatović, S Glumac, D Bajić, ... Physiological measurement 36 (4), 727, 2015 | 42 | 2015 |
| Cardiovascular variability and β-ars gene expression at two stages of doxorubicin–induced cardiomyopathy M Vasić, T Lončar-Turukalo, T Tasić, M Matić, S Glumac, D Bajić, ... Toxicology and applied pharmacology 362, 43-51, 2019 | 20 | 2019 |
| Hemodynamic effects of HPMA copolymer based doxorubicin conjugate: a randomized controlled and comparative spectral study in conscious rats HY Cheah, O Šarenac, JJ Arroyo, M Vasić, M Lozić, S Glumac, SZ Hoe, ... Nanotoxicology 11 (2), 210-222, 2017 | 20 | 2017 |
| MoËT: Mixture of Expert Trees and its application to verifiable reinforcement learning M Vasić, A Petrović, K Wang, M Nikolić, R Singh, S Khurshid Neural Networks 151, 34-47, 2022 | 18 | 2022 |
| Programming and training rate-independent chemical reaction networks M Vasić, C Chalk, A Luchsinger, S Khurshid, D Soloveichik Proceedings of the National Academy of Sciences 119 (24), e2111552119, 2022 | 12 | 2022 |
| Phenomapping for classification of doxorubicin-induced cardiomyopathy in rats V Pajović, C Kovácsházi, M Kosić, M Vasić, L Đukić, GB Brenner, Z Giricz, ... Toxicology and Applied Pharmacology 423, 115579, 2021 | 7 | 2021 |
| The influence of subchronic co-application of vitamins B6 and folic acid on cardiac oxidative stress and biochemical markers in monocrotaline-induced heart failure in male … J Jakovljevic Uzelac, T Djukic, S Mutavdzin, S Stankovic, ... Canadian Journal of Physiology and Pharmacology 98 (2), 93-102, 2020 | 7 | 2020 |
| Paroxetine mitigates cardiac remodelling by doxorubicin and increases survival M Kosić, Z Nešić, S Glumac, M Vasić, V Pajović, B Savić, ... Biomedicine & Pharmacotherapy 145, 112411, 2022 | 6 | 2022 |
| Terrain drainage in the landslide area on the Danube slope in Novi Sad M Vasić, M Đogo, B Jelisavac Technical Gazette 22 (4), 1075-1083, 2015 | 1 | 2015 |
| G protein receptor kinase type 2: a novel target in cardiovascular drug development MS Vasić, ŽNM Japundžić Hospital Pharmacology-International Multidisciplinary Journal 1 (2), 109-114, 2014 | 1 | 2014 |
| GRK-2 inhibitor lek kandidat u terapiji srčane insuficijencije M Vasić, ŽN Japundžić Srce i krvni sudovi 32 (4), 304-308, 2013 | 1 | 2013 |
| Determination of muscle fiber types expressing ANKRD2 M Novković, M Vasić, J Jasnić, E Milošević, M Milovanović, S Savić, ... CoMBoS2–the Second Congress of Molecular Biologists of Serbia, Abstract Book …, 2023 | | 2023 |
| Phenomapping Doxorubicin-induced Cardiomyopathy D Bajić, V Pajović, M Matić, M Vasić, O Šarenac, N Japundžić-Žigon 2020 11th Conference of the European Study Group on Cardiovascular …, 2020 | | 2020 |
| Varijabilitet srčane frekvencije i ekspresija ß-adrenergičkih receptora u kardiomiopatiji izazvanoj doksorubicinom MS Vasić Универзитет у Београду, 2019 | | 2019 |
| Kriminološke i socijalne karakteristike alkoholičara na teritoriji opštine Bajina Bašta M Vasić | | 2019 |
| Yamaguchi syndrome (apical hypertrophic cardiomyopathy) GK Sharma, M Vasic, A Kumar, PA Jones Consultant 57 (10), 2017 | | 2017 |
| Heart rate variability and baroreceptor reflex sensitivity in doxorubicin-induced cardiomyopathy T Loncar-Turukalo, M Vasic, G Mijatovic, N Japundzic-Zigon, D Bajic 2014 8th Conference of the European Study Group on Cardiovascular …, 2014 | | 2014 |
| Promene senzitivnosti baroreceptorsko g refleksa kod toksične miokardiopatije izazvane doksorubicinom A Ninić, M Vasić, S Glumac, N Žigon Medicinski podmladak 65 (1-2), 46-50, 2014 | | 2014 |
